Premium
A rare complication after allogeneic stem cell transplantation: post‐transplant erythrocytosis
Author(s) -
Atilla Erden,
Topcuoglu Pervin,
Ataca Pinar,
Pekcan Gultekin,
Bozdag Sinem Civriz,
Yuksel Meltem Kurt,
Ozcan Muhit,
Gurman Gunhan,
Toprak Selami Kocak
Publication year - 2016
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.12741
Subject(s) - medicine , complication , transplantation , aplastic anemia , myeloid leukemia , hematopoietic stem cell transplantation , stem cell , haematopoiesis , myeloid , pathogenesis , surgery , immunology , bone marrow , biology , genetics
Post‐transplant erythrocytosis is an infrequent complication and has been reported after allogeneic hematopoietic stem cell transplantation (allo‐HSCT) in aplastic anemia, acute myeloid leukemia, and chronic myeloid leukemia. The pre‐disposing factors and treatment are not clearly defined. We present 11 post‐transplant erythrocytosis cases. More studies should be conducted to distinguish the pathogenesis and follow‐up for this rare complication.